Tactile Systems Technology, Inc.

TCMD ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $329.5M $293.0M $274.4M $246.8M $208.1M $187.1M $189.5M $143.8M
Cost of Revenue $79.4M $76.3M $79.3M $70.8M $59.8M $54.3M $55.3M $41.5M
Gross Profit $250.1M $216.7M $195.1M $176.0M $148.2M $132.8M $134.2M $102.3M
Gross Margin 75.9% 74.0% 71.1% 71.3% 71.2% 71.0% 70.8% 71.1%
Operating Expenses
Research & Development $8.5M $8.8M $7.8M $7.1M $5.7M $5.3M $5.2M $5.3M
SG&A Expense $88.7M $71.1M $62.1M $60.8M $56.8M $51.3M $39.5M $33.6M
Operating Income $29.3M $22.2M $18.0M $-12.8M $-1.8M $-3.6M $10.5M $3.0M
Operating Margin 8.9% 7.6% 6.6% -5.2% -0.8% -1.9% 5.5% 2.1%
Interest Expense — — — — — — — —
Pretax Income $31.3M $23.5M $15.8M $-15.5M $-2.3M $-2.3M $11.1M $3.5M
Income Tax Expense $12.3M $6.5M $-12.7M $2.4M $9.5M $-1.6M $158.0K $-3.1M
Net Income $19.1M $17.0M $28.5M $-17.9M $-11.8M $-620.0K $11.0M $6.6M
Net Margin 5.8% 5.8% 10.4% -7.2% -5.7% -0.3% 5.8% 4.6%
EPS (Basic) $0.83 $0.71 $1.24 $-0.89 $-0.60 $-0.03 $0.58 $0.36
EPS (Diluted) $0.82 $0.70 $1.23 $-0.89 $-0.60 $-0.03 $0.56 $0.34
Shares Outstanding (Basic) 22.9M 23.9M 22.9M 20.1M 19.7M 19.3M 18.9M 18.3M
Shares Outstanding (Diluted) 23.3M 24.1M 23.2M 20.1M 19.7M 19.3M 19.6M 19.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →